SERPINB5 and breast carcinoma: Since we also demonstrated that nuclear maspin is crucial for better prognosis and inhibition of proliferation of breast tumors in vivo it suggests that nuclear maspin may be successfully used as a prognostic marker and potential genetic drug for gene therapy for breast cancer.